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INTRODUCTION: 
Diabetes Mellitus is a genetic disorder, with abnormal elevated 
serum glucose, due to partial or absolute lack of Insulin, although in 
type –II diabetes, insulin is either normal or elevated, and the etiology 
of the disease mainly relay on the receptor for the insulin. The clinical 
manifestations of diabetes are metabolic disorders, neuropathic and 
cardiovascular, abnormalities. Diabetes Mellitus is not a Curable 
disease, but the manifestations can be prevented [1]. The Vascular 
endothelium’s basal Membrane are thickened, which is defined as 
microangiopathy. Still the pathogeneses of this later abnormality, 
is not fully understood, but it is directly related to hyperglycemia 
among diabetic patients. There is a controversial argument about 
the neuropathy, but it can be related to the microangiopathy, and 
disorders in the peripheral nervous system [2],[3]. Arthrosclerosis, 
which is mainly seen in diabetes Mellitus patients, and can be 
accompanied by neuropathy on various organs, including the 
hearing system. [2], [3].The adverse effects on various organs and 
hearing ability can be the result of disorders of blood , and reduction 
of nutritional transport , due to thickness of Vascular membrane or 
indirectly due Vascular Constriction, which leads to degeneration of 
eight nerve. Angiopathy in the hearing System can be due to above 
observations [4].
The pathological tests which were carried out on the temporal bone 
in diabetic patients, demonstrated that the thickness of Vascular 
membrane is 10-20 times more than in ordinary Subjects. Other 
Studies which was Carried out on the temporal bone showed the 
increased Vascular thickness of Stria Vascularis and Modilius [5]. 
The increased vascular thickness and reduction of vascular lumen 
in internal auditory artery are more severe.Previous studies showed 
that diabetes was responsible for abnormality in various organs, as 
well as hearing system and Sudden deafness (6). In one of the Study 
which was Carried out on 51 diabetic Patients,with the age group 
from 8-21 years with 13 control subjects, no significant differences 
was not found in their hearing test assessments [7]. 
In another Study, it was noticed that incidence of hearing loss 
was higher among diabetic patients, but there was no Significant 
Correlation between hearing loss and duration of diabetes.This 
present study was designed to Compare the scale of hearing loss 
among diabetic patients and Compare the findings with matched 
age non- diabetic Subjects. 
MATERIAL AND METHODS
This study was carried out at an ENT clinic of 5 th Azar hospital 
in Gorgan during 2008, the patients were diagnosed as diabetic 
patient by endocrinology and they were a routine monthly visitor of 
the Diabetes clinic at the Same hospital. In this Study 50 patients 
were selected by simple random sampling and their Consent were 
obtained before taking them as a Case group. Patients who did not 
have proper files in the clinic or had the history of either Sound or head 
trauma and tympanic membrane perforation were excluded from 
this study. The questionnaire containing demographic characteristic 
of age, gender, education, place of residence, duration of diabetes, 
type of consupmtion of drugs, audio logic Complain were filled for 
each patient as well as for other matched control group. 
The patients which were visitors of 5th Azar hospital were chosen 
as control group. The hearing test of PTA , Tempnometry AR 
were applied to assess the hearing of the subjects. In this study 
when the mean of BC in frequency of 500, 1000, 2000 were more 
than 20dB, it was Considered as a base for hearing loss. Those 
patients with Tempometry of type B and C were excluded from this 
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ABSTRACT
Introduction: The prevalence of Diabetes Mellitus is steadily 
increasing. This is a multi- systemic abnormality, causing 
side- effects which are mainly irreversible. Hearing loss is 
one of the common symptoms, and there are many studies, 
with contradictory results. Aim of this study was to compare 
the hearing loss among diabetic with non- diabetic patients. 
Material and Methods: In this study 50 diabetic patients were 
chosen randomly from those overt diabetic patients referred to 
the Diabetes clinic in Gorgan hospital northern Iran, 50 other 
patients who referred to the 5th Azar hospital, with any other ENT 
complaint were also randomly chosen as control group. The case 
and control groups were matched. Demographic questionnaires 
were filled for each subjects in case and control groups, and 
those with intervening factors were omitted from this study. 
Data were analyzed using SPSS. Results:In this study 66% and 
34% of participants were men and women respectively. The age 
distribution of the patient were 15-75 years. The hearing loss 
among diabetic patients and non- diabetic subjects were 16% 
and 5% respectively, which showed that the diabetic patient has 
3.2 times more possibility to acquire hearing problem. It was also 
shown, that there was a direct correlation between increasing 
age and hearing loss. More women are at risk, of getting hearing 
loss than men. The hearing loss also has a correlation with the 
duration of disease onset and the consumption of Glibanclamid.
ConclusionThe careful periodical assessment of hearing loss, 
and the application of hearing facilities to improve the quality 
of diabetic patients life is recommended due to chronic and 
irreversible Symptom of the disease. 
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study. The patients were sub- divided according to their age group. 
The hearing system of the control group in this study were also 
assessed, and they were also clinically and para-clinically evaluated, 
Statistical divisions were obtained for quantitative findings such as 
blood glucose, age and for qualitative findings such as, gender, the 
amount of consumed drugs. The number and percentage were 
applied to report the Statistical indices. The gathered information 
were entered into Computer and SPSS software was used to 
analyze the data. 
The patients names were excluded, and a code-name was given to 
each subjects to observe the animosity of Subjects participating in 
this study. 
RESULTS 
In this study, the 66 %, and 34 % of participants were males and 
females respectively The findings of this result indicated that the rate 
of hearing loss among diabetic case group and non- diabetic control 
group were 16% and 5% respectively. It means the diabetic patient 
are 3.2 times more at risk of having hearing loss, compared to non- 
diabetic Subjects.
The age distribution of patients were Summarized and, the patients 
were divided in 4 age groups according to the [Table/Fig 1]. The 
patients also were divided according to their gender. 
The patients were also recorded according to the duration of diabetes 
and the type of drugs consumed, these information were presented 
in [Table/Fig 2] and [Table/Fig 3]. 
The distribution of hearing loss among different age group 
were studied, and it was found, there is a Steady increase in 
hearing loss with an increase in age of diabetic patients, but 
this observation Statistically was not Significant. The hearing 
loss was also analysed according to the gender difference and 
it was found hearing loss among men and women was 11.8% 
and 18.8% respectively, although this difference Statistically was 
not Significant. The hearing loss was also evaluated according 
to the duration of diabetes onset and it was found the Scale of 
hearing loss increased as the duration of diabetes increased and 
this finding was statistically Significant Table-2( p <0.05). The 
Scale of hearing loss was also studied according to the type 
of drugs consumed by the Patients and it was found that the 
Scale of hearing loss among those patient with Glibenclamid and 
Metformin were 23.1% and 5.3 % respectively. It was noticed the 
patients on Insulin did not show any hearing loss [Table/Fig 3]
DISCUSSION
Our Study (which mainly covered the younger age group), compared 
to some other study, showed that the prevalence of hearing loss 
among our diabetic patients was 16%, while the same index among 
our non- diabetic control was 5%, it means that diabetic patient 
faced a 3.2 times more risk of gaining hearing loss. Other studies 
which have been carried out have shown contradictory results. In a 
study by Diniz and Guidu, which was also carried out on 50 diabetic 
patients, as a case group and compared them with non- diabetic 
subjects, the Scale of their results was higher than our results. This 
difference might be attributed to the younger population in our study. 
They found 38% of their diabetic patient and 2.4% of non- diabetic 
subjects to have hearing loss [1]. The reason for their results of high 
incidence of hearing loss may be due to their elderly patients. In a 
study by Rege hearing loss was also reported among children with 
diabetes [4]. In study of Sieger et al on diabetic patients, they did 
not find any significant differences of hearing loss in diabetic and 
non- diabetic patients [7]. In our Study, the increasing hearing loss 
showed to have a direct Correlation with the duration of diabetes in 
patients, but this observation statistically did not have any meaning. 
It seems, age, in addition to diabetes, can Cause hearing loss. In 
a study by Diniz and Guida which reported higher Prevalence of 
hearing loss among patients with older age it means in addition to 
diabetes age also plays an important role in hearing loss [8]. A study 
by Donald et al, indicated that the patient with < 50 years of age, has 
lower risk of hearing loss [9].
In our study the Prevalence of hearing loss had direct correlation 
with the duration of disease itself, which looks logical, because the 
duration of diabetes onset has a pathological effect on the hearing 
System. Our finding indicated that diabetic patient on Insulin therapy 
do not loose their hearing ability. Also a study by Chon et al indicated 
that the control of diabetes with insulin can have a better prognosis 
for hearing loss, for diabetic patients, [10] The Sample population 
in our study was small, but it seems that the blood glucose Control 
by Insulin, can be one of the probable criteria, to observe the latter 
observation in this present study. 
CONCLUSION
In regard to incidence of chronic and irreversible complications 
among diabetic patients, periodical assessment of various organs of 
the body, including hearing system, should be carried out carefully, 
to provide better life condition for the diabetic patients.
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Age
 
Hearing loss
 
Hearing loss
Non hearing 
loss
Non hearing 
loss
15-30 0 0 5 100
31-45 1 10 9 90
46-60 6 90 14 70
51-75 1 100 0 0
[Table/Fig 1]: The prevalence of hearing loss according to age
Duration of 
Diabetes-  
(in yrs)
Hearing loss 
Number
hearing loss 
Number
Non hearing 
loss 
Number
Non hearing 
loss 
Number
less than 5 2 10.5 17 89.5
5-10 3 12.5 21 87.5
11-15 2 33.3 4 66.6
More than 15 1 100 0 0
[Table/Fig 2]: The prevalence of hearing loss according to length of 
diabetes
 
Drug  
Consumed
 
Hearing loss 
Number
 
hearing loss 
Number
Non hearing 
loss 
Number
Non hearing 
loss 
Number
Glibenclamed 6 23.1 20 76.9
Methfomin 1 5.3 21 94.7
Insulin 0 0 9 100
[Table/Fig 3]:  The prevalence of hearing loss according to the type of 
drug consumed
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